Literature DB >> 17720975

Mapping the binding site on small ankyrin 1 for obscurin.

Maegen A Borzok1, Dawn H Catino, James D Nicholson, Aikaterini Kontrogianni-Konstantopoulos, Robert J Bloch.   

Abstract

Small ankyrin 1 (sAnk1), an integral protein of the sarcoplasmic reticulum encoded by the ANK1 gene, binds with nanomolar affinity to the C terminus of obscurin, a giant protein surrounding the contractile apparatus in striated muscle. We used site-directed mutagenesis to characterize the binding site on sAnk1, specifically addressing the role of two putative amphipathic, positively charged helices. We measured binding qualitatively by blot overlay assays and quantitatively by surface plasmon resonance and showed that both positively charged sequences are required for activity. We showed further that substitution of a lysine or arginine with an alanine or glutamate located at the same position along either of the two putative helices has similar inhibitory or stimulatory effects on binding and that the effects of a particular mutation depended on the position of the mutated amino acid in each helix. We modeled the structure of the binding region of sAnk1 by homology with ankyrin repeats of human Notch1, which have a similar pattern of charged and hydrophobic residues. Our modeling suggested that each of the two positively charged sequences forms pairs of amphipathic, anti-parallel alpha-helices flanked by beta-hairpin-like turns. Most of the residues in homologous positions along each helical unit have similar, though not identical, orientations. CD spectroscopy confirmed the alpha-helical content of sAnk1, approximately 33%, predicted by the model. Thus, structural and mutational studies of the binding region on sAnk1 for obscurin suggest that it consists of two ankyrin repeats with very similar structures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720975     DOI: 10.1074/jbc.M704089200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

2.  Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease.

Authors:  Shane R Cunha; Solena Le Scouarnec; Jean-Jacques Schott; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2008-08-27       Impact factor: 5.000

3.  The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.

Authors:  Diana L Ford-Speelman; Joseph A Roche; Amber L Bowman; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2009-07-15       Impact factor: 4.138

Review 4.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

5.  Loss of actomyosin regulation in distal arthrogryposis myopathy due to mutant myosin binding protein-C slow.

Authors:  Maegen A Ackermann; Puja D Patel; Jane Valenti; Yasuharu Takagi; Earl Homsher; James R Sellers; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2013-05-08       Impact factor: 5.191

6.  Myosin binding protein-C slow is a novel substrate for protein kinase A (PKA) and C (PKC) in skeletal muscle.

Authors:  Maegen A Ackermann; Aikaterini Kontrogianni-Konstantopoulos
Journal:  J Proteome Res       Date:  2011-09-22       Impact factor: 4.466

7.  Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.

Authors:  Maegen A Ackermann; Brendan King; Nicole A P Lieberman; Prameela J Bobbili; Michael Rudloff; Christopher E Berndsen; Nathan T Wright; Peter A Hecker; Aikaterini Kontrogianni-Konstantopoulos
Journal:  J Mol Cell Cardiol       Date:  2017-08-04       Impact factor: 5.000

Review 8.  Obscure functions: the location-function relationship of obscurins.

Authors:  Heather R Manring; Olivia A Carter; Maegen A Ackermann
Journal:  Biophys Rev       Date:  2017-03-29

Review 9.  Anchoring skeletal muscle development and disease: the role of ankyrin repeat domain containing proteins in muscle physiology.

Authors:  Jin-Ming Tee; Maikel P Peppelenbosch
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-08       Impact factor: 8.250

10.  Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.

Authors:  Shane R Cunha; Peter J Mohler
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.